Current perspectives on corneal collagen crosslinking (CXL)

@article{Subasinghe2018CurrentPO,
  title={Current perspectives on corneal collagen crosslinking (CXL)},
  author={Sandeepani Kanchana Subasinghe and Kelechi C. Ogbuehi and George J. Dias},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={2018},
  volume={256},
  pages={1363-1384}
}
  • Sandeepani Kanchana Subasinghe, Kelechi C. Ogbuehi, George J. Dias
  • Published in
    Graefe's Archive for Clinical…
    2018
  • Medicine
  • Corneal collagen crosslinking has revolutionized the treatment of keratoconus and post-refractive corneal ectasia in the past decade. Corneal crosslinking with riboflavin and ultraviolet A is proposed to halt the progression of keratectasia. In the original “Conventional Dresden Protocol” (C-CXL), the epithelium is removed prior to the crosslinking process to facilitate better absorption of riboflavin into the corneal stroma. Studies analyzing its short- and long-term outcomes revealed that… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    2
    Twitter Mentions

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 133 REFERENCES

    Long-term results of Graefes Arch Clin Exp Ophthalmol corneal collagen crosslinking for progressive keratoconus

    • M De Bernardo, L Capasso, +5 authors N Rosa
    • J Optom 8(3):180–186
    • 2015
    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL